Paratek Pharmaceuticals Inc. | Key People and Executives
Michael F. Bigham
Chairman & Chief Executive Officer
Evan Loh
President, COO, Director & Chief Medical Officer
Rolf K. Hoffmann
Director
Kristine Peterson
Independent Director
Timothy R. Franson
Independent Director
Jeffrey L. Stein
Independent Director
Robert Samuel Radie
Independent Director
Thomas John Dietz
Independent Director
Michael F. Bigham
Chairman & Chief Executive Officer
Evan Loh
President, COO, Director & Chief Medical Officer
Douglas W. Pagán
Chief Financial & Accounting Officer
Paul McGovern
Vice President-Clinical & Medical Affairs
S. Ken Tanaka
Vice President-Research & Development
Benjamin J. Strain
ED, Head-IR & Corporate Communications
William M. Haskel
Secretary, Chief Compliance Officer & Senior VP
Evan Tzanis
Chief Development Officer
Adam Woodrow
Chief Commercial Officer & Vice President
Jeanne Y. Jew
Senior Vice President-Business Development
Judith Steenbergen
Executive Director-Microbiology
Raj Padmanabhan
Vice President-Information Technology
Susan M. Perkins
Vice President-Intellectual Property
Rolf K. Hoffmann
Director
Christine R. Coyne
Vice President-Marketing
Sarah Higgins
Vice President & Controller
Regina M. DeTore Paglia
Senior Vice President-Human Resources
Randy Brenner
SVP-Regulatory, Quality & Technical Operations
Kristine Peterson
Independent Director
Timothy R. Franson
Independent Director
Jeffrey L. Stein
Independent Director
Robert Samuel Radie
Independent Director
Thomas John Dietz
Independent Director
| Address |
75 Park Plaza
Boston Massachusetts 02116
United States
|
|
Employees
|
- |
| Website |
http://www.paratekpharma.com |
| Updated |
07/08/2019 |
| Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include Omadacycline and Sarecycline, which are used for the treatment of serious community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections, and urinary tract infections. The company was founded in February 2001 and is headquartered in Boston, MA. |
